Study details
Enrolling now
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
BioLab Holdings
NCT IDNCT07364630ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
50
Study length
about 1.1 years
Ages
18+
Locations
1 site in PA
What this study is about
This trial is testing different treatments for nonhealing diabetic foot ulcers and venous leg ulcers. It compares human placental membrane products with standard care, along with various wrap types, to see which works best.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Membrane Wrap-Hydro™ DFU
- 2.Membrane Wrap-Hydro™ VLU
- 3.Membrane Wrap-Lite™ DFU
- +3 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Adverse Events, Determine improvement in Quality of Life, Pain in patients who present with VAS greater than 4, Time to Closure